Knapp S - Search Results

1

Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.

Knapp S, Zakaria Z, Hashem M, Zaghla H, Khakoo SI, Waked I, Thursz M, Abdelwahab SF. Knapp S, et al. Hepatol Int. 2015 Apr;9(2):251-7. doi: 10.1007/s12072-015-9619-z. Epub 2015 Mar 12. Hepatol Int. 2015. PMID: 25788203

2

A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.

Knapp S, Warshow U, Ho KM, Hegazy D, Little AM, Fowell A, Alexander G, Thursz M, Cramp M, Khakoo SI. Knapp S, et al. Gastroenterology. 2011 Jul;141(1):320-5, 325.e1-2. doi: 10.1053/j.gastro.2011.04.005. Epub 2011 Apr 14. Gastroenterology. 2011. PMID: 21600205 Free PMC article.

3

Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians.

Zakaria ZA, Knapp S, Hashem M, Zaghla H, Thursz M, Waked I, Abdelwahab S. Zakaria ZA, et al. Among authors: knapp s. Immunol Res. 2019 Feb;67(1):123-133. doi: 10.1007/s12026-018-9035-2. Immunol Res. 2019. PMID: 30402710

4

Detection of allele specific differences in IFNL3 (IL28B) mRNA expression.

Knapp S, Meghjee N, Cassidy S, Jamil K, Thursz M. Knapp S, et al. BMC Med Genet. 2014 Oct 5;15:104. doi: 10.1186/s12881-014-0104-7. BMC Med Genet. 2014. PMID: 25287681 Free PMC article.

5

Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.

Knapp S, Warshow U, Hegazy D, Brackenbury L, Guha IN, Fowell A, Little AM, Alexander GJ, Rosenberg WM, Cramp ME, Khakoo SI. Knapp S, et al. Hepatology. 2010 Apr;51(4):1168-75. doi: 10.1002/hep.23477. Hepatology. 2010. PMID: 20077564 Free PMC article.

6

Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection.

Hennig BJ, Frodsham AJ, Hellier S, Knapp S, Yee LJ, Wright M, Zhang L, Thomas HC, Thursz M, Hill AV. Hennig BJ, et al. Among authors: knapp s. Liver Int. 2007 Oct;27(8):1134-43. doi: 10.1111/j.1478-3231.2007.01518.x. Liver Int. 2007. PMID: 17845543

7

Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection.

Knapp S, Hennig BJ, Frodsham AJ, Zhang L, Hellier S, Wright M, Goldin R, Hill AV, Thomas HC, Thursz MR. Knapp S, et al. Immunogenetics. 2003 Sep;55(6):362-9. doi: 10.1007/s00251-003-0594-5. Epub 2003 Aug 26. Immunogenetics. 2003. PMID: 12942209

8

Effect of a thrombin receptor (protease-activated receptor 1, PAR-1) gene polymorphism in chronic hepatitis C liver fibrosis.

Martinelli A, Knapp S, Anstee Q, Worku M, Tommasi A, Zucoloto S, Goldin R, Thursz M. Martinelli A, et al. Among authors: knapp s. J Gastroenterol Hepatol. 2008 Sep;23(9):1403-9. doi: 10.1111/j.1440-1746.2007.05220.x. Epub 2007 Nov 14. J Gastroenterol Hepatol. 2008. PMID: 18005014

9

The clinical role of circulating free tumor DNA in gastrointestinal malignancy.

Howell JA, Khan SA, Knapp S, Thursz MR, Sharma R. Howell JA, et al. Among authors: knapp s. Transl Res. 2017 May;183:137-154. doi: 10.1016/j.trsl.2016.12.006. Epub 2016 Dec 22. Transl Res. 2017. PMID: 28056336 Free article. Review.

10

Autoregulatory role of interleukin-10 in hepatitis C patients treated with IFN-alpha.

Luik A, Knapp S, Thursz M, Thomas HC, Schlaak JF. Luik A, et al. Among authors: knapp s. J Interferon Cytokine Res. 2004 Oct;24(10):585-93. doi: 10.1089/jir.2004.24.585. J Interferon Cytokine Res. 2004. PMID: 15626155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,332 results

Search Page

Filters